Workshops of the National Academies Roundtable on Science and Welfare in Laboratory Animal Use (ILAR Roundtable)
Project Number5R13FD006967-02
Contact PI/Project LeaderSYLVINA, TERESA
Awardee OrganizationNATIONAL ACADEMY OF SCIENCES
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Application Title: Workshops of the National Academies' Roundtable on Science and Welfare
in Laboratory Animal Use (ILAR Roundtable)
Funding Opportunity Title: FDA Scientific Conference Grant Program (R13); PAR-19-306.
This request is for funding from the Office of the FDA Commissioner (OC/OCS/OCET).
The Institute for Laboratory Animal Research (ILAR) of the National Academies of Sciences,
Engineering, and Medicine established the Roundtable on Science and Welfare in Laboratory
Animal Use in the Fall of 2013. The purpose of the Roundtable is to foster communication
and problem solving among the many different constituencies with strong interests in the use
and welfare of laboratory animals in research and testing, including, government agencies,
pharmaceutical and consumer product corporations, vendors, animal advocacy groups,
professional societies, and academic institutions , including scientists and veterinarians. The
workshops will be open to the public and webcasted, and there will be no fee charged to attend
or view the workshop via the web.
This application requests funds from the U.S. Food and Drug Administration to provide partial
support toward convening up to two workshops a year, beginning in 2020 for a period of five
years under the auspices of the Roundtable. Each workshop will focus on a critical issue related
to the science and welfare of laboratory animal use, such as Micro-Physiological Systems for
Efficacy and Safety Studies: A Workshop on Advances in Organs-On-Chip Technologies for
Animals; The 4th R: Rehoming and Retirement of Non-Human Primates Used in Research; the
Ethics and Use of Genetic Modifications in Xenotransplantation; and Laboratory Animal Use and
the One Health Paradigm. The workshops present opportunities for 1) outreach to and dialogue
with all communities who share an interest in the use of laboratory animals in research; 2) sharing
of cutting-edge scientific information; and 3) increased understanding of the topics and
identification of possible follow-on activities to improve the quality of biomedical research and
laboratory animal welfare.
Animal-based research is a fundamental component of the preclinical research and development
and proof-of-concept studies of drugs, biologics and medical devices. Ensuring the highest
quality of these studies while maintaining appropriate care and use of the animals used depends
on building trust and maintaining and information sharing among the research, scientific and
veterinary medical communities. As such, the purpose of Roundtable and its workshops is
consistent with the mission of the FDA: "…protecting the public health by assuring the safety,
efficacy and security of human and veterinary drugs, biological products, medical devices, our
nation's food supply, cosmetics, and products that emit radiation”.
Public Health Relevance Statement
PROJECT SHORT NARRATIVE
The purpose of the ILAR Roundtable is to foster communication and problem solving among
the many different constituencies with strong interests in the use and welfare of laboratory
animals in research and testing, including, government agencies, pharmaceutical and consumer
product corporations, vendors, animal advocacy groups, professional societies, and academic
institutions , including scientists and veterinarians. The objectives of all workshops organized
by the ILAR Roundtable are to: 1 ) provide a forum in which to stimulate open dialogue, exchange
information and foster communication ; 2) promote collaboration among a wide range of entities
interested in the development of cutting edge laboratory animal research topics; and 3) facilitate
discussion on more effective, efficient and humane use of animals and use of animal alternatives
in biomedical research.
No Sub Projects information available for 5R13FD006967-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R13FD006967-02
Patents
No Patents information available for 5R13FD006967-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R13FD006967-02
Clinical Studies
No Clinical Studies information available for 5R13FD006967-02
News and More
Related News Releases
No news release information available for 5R13FD006967-02
History
No Historical information available for 5R13FD006967-02
Similar Projects
No Similar Projects information available for 5R13FD006967-02